In silico and in vitro drug screening identifies new therapeutic approaches for Ewing sarcoma

The long-term overall survival of Ewing sarcoma (EWS) patients remains poor; less than 30% of patients with metastatic or recurrent disease survive despite aggressive combinations of chemotherapy, radiation and surgery. To identify new therapeutic options, we employed a multi-pronged approach using...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Pessetto, Ziyan Y., Chen, Bin, Alturkmani, Hani, Hyter, Stephen, Flynn, Colleen A., Baltezor, Michael, Ma, Yan, Rosenthal, Howard G., Neville, Kathleen A., Weir, Scott J., Butte, Atul J., Godwin, Andrew K.
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5354814/
https://ncbi.nlm.nih.gov/pubmed/27863422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13385
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars